578 related articles for article (PubMed ID: 29445373)
1. Tissue-Dependent Tumor Microenvironments and Their Impact on Immunotherapy Responses.
Oliver AJ; Lau PKH; Unsworth AS; Loi S; Darcy PK; Kershaw MH; Slaney CY
Front Immunol; 2018; 9():70. PubMed ID: 29445373
[TBL] [Abstract][Full Text] [Related]
2. Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.
Balta E; Wabnitz GH; Samstag Y
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072260
[TBL] [Abstract][Full Text] [Related]
3. Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy.
Devaud C; Westwood JA; John LB; Flynn JK; Paquet-Fifield S; Duong CP; Yong CS; Pegram HJ; Stacker SA; Achen MG; Stewart TJ; Snyder LA; Teng MW; Smyth MJ; Darcy PK; Kershaw MH
Mol Ther; 2014 Jan; 22(1):18-27. PubMed ID: 24048441
[TBL] [Abstract][Full Text] [Related]
4. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy.
Pitt JM; Marabelle A; Eggermont A; Soria JC; Kroemer G; Zitvogel L
Ann Oncol; 2016 Aug; 27(8):1482-92. PubMed ID: 27069014
[TBL] [Abstract][Full Text] [Related]
5. Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy.
Phuengkham H; Ren L; Shin IW; Lim YT
Adv Mater; 2019 Aug; 31(34):e1803322. PubMed ID: 30773696
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive cells in tumor immune escape and metastasis.
Liu Y; Cao X
J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
[TBL] [Abstract][Full Text] [Related]
7. Suppressing immunotherapy by organ-specific tumor microenvironments: what is in the brain?
Zhang C; Yu D
Cell Biosci; 2019; 9():82. PubMed ID: 31624532
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory effects of current cancer treatment and the consequences for follow-up immunotherapeutics.
Mooradian MJ; Sullivan RJ
Future Oncol; 2017 Aug; 13(18):1649-1663. PubMed ID: 28776423
[TBL] [Abstract][Full Text] [Related]
9. Progress in tumor-associated macrophage (TAM)-targeted therapeutics.
Ngambenjawong C; Gustafson HH; Pun SH
Adv Drug Deliv Rev; 2017 May; 114():206-221. PubMed ID: 28449873
[TBL] [Abstract][Full Text] [Related]
10. The Role of Tumor Microenvironment in Cancer Immunotherapy.
Frankel T; Lanfranca MP; Zou W
Adv Exp Med Biol; 2017; 1036():51-64. PubMed ID: 29275464
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
Wang H; Franco F; Ho PC
Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935
[TBL] [Abstract][Full Text] [Related]
12. Cross-talk between tumors at anatomically distinct sites.
Oliver AJ; Darcy PK; Trapani JA; Kershaw MH; Slaney CY
FEBS J; 2021 Jan; 288(1):81-90. PubMed ID: 32248616
[TBL] [Abstract][Full Text] [Related]
13. Tissue Site and the Cancer Immunity Cycle.
Horton BL; Fessenden TB; Spranger S
Trends Cancer; 2019 Oct; 5(10):593-603. PubMed ID: 31706507
[TBL] [Abstract][Full Text] [Related]
14. Targeting the tumor microenvironment by immunotherapy: part 2.
Leibovici J; Itzhaki O; Huszar M; Sinai J
Immunotherapy; 2011 Nov; 3(11):1385-408. PubMed ID: 22053888
[TBL] [Abstract][Full Text] [Related]
15. Radiation-Induced Transformation of Immunoregulatory Networks in the Tumor Stroma.
Martinez-Zubiaurre I; Chalmers AJ; Hellevik T
Front Immunol; 2018; 9():1679. PubMed ID: 30105016
[TBL] [Abstract][Full Text] [Related]
16. Modulating barriers of tumor microenvironment through nanocarrier systems for improved cancer immunotherapy: a review of current status and future perspective.
Lan H; Zhang W; Jin K; Liu Y; Wang Z
Drug Deliv; 2020 Dec; 27(1):1248-1262. PubMed ID: 32865029
[TBL] [Abstract][Full Text] [Related]
17. Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape.
Osipov A; Saung MT; Zheng L; Murphy AG
J Immunother Cancer; 2019 Aug; 7(1):224. PubMed ID: 31439034
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles for tumor immunotherapy.
Zang X; Zhao X; Hu H; Qiao M; Deng Y; Chen D
Eur J Pharm Biopharm; 2017 Jun; 115():243-256. PubMed ID: 28323111
[TBL] [Abstract][Full Text] [Related]
19. Tissues and Tumor Microenvironment (TME) in 3D: Models to Shed Light on Immunosuppression in Cancer.
Ho T; Msallam R
Cells; 2021 Apr; 10(4):. PubMed ID: 33917037
[TBL] [Abstract][Full Text] [Related]
20. Mast cells as targets for immunotherapy of solid tumors.
Oldford SA; Marshall JS
Mol Immunol; 2015 Jan; 63(1):113-24. PubMed ID: 24698842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
